Advertisement
Singapore markets close in 1 hour 21 minutes
  • Straits Times Index

    3,291.12
    +25.17 (+0.77%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,972.46
    +434.65 (+2.34%)
     
  • FTSE 100

    8,425.79
    +44.44 (+0.53%)
     
  • Bitcoin USD

    63,200.68
    +1,838.02 (+3.00%)
     
  • CMC Crypto 200

    1,359.70
    +1.69 (+0.12%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • Dow

    39,387.76
    +331.36 (+0.85%)
     
  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     
  • Gold

    2,374.80
    +34.50 (+1.47%)
     
  • Crude Oil

    79.77
    +0.51 (+0.64%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • FTSE Bursa Malaysia

    1,601.53
    +0.31 (+0.02%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

What's Going On With Novavax Stock?

What's Going On With Novavax Stock?

Shares of Novavax (NASDAQ: NVAX) have been extremely volatile as the market tries to value the company's COVID-19 vaccine. In January of last year, the company's stock was valued at $4 a share. The stock zoomed higher when COVID-19 hit, the tiny company introduced its vaccine candidate, and saw early success in clinical trials.